FDA NDC Directory · JSON-LD · Markdown

ELELYSO

NDC 0069-0106 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTaliglucerase alfa
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryBiologic License Application · App BLA022458
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTALIGLUCERASE ALFA (200 U/5mL)
Marketing started20120501
Package count1

External sources

Source: openFDA. Public-domain (CC0).